en

PRODUCT DETAIL

Pazopanib G.L. Pharma 200 mg filmom obalené tablety

Code 0820E
MA number 44/0123/22-S
Product Form: tbl flm 30x200 mg (blis.Al/PVC/PE/PVDC)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX03 Pazopanib
Shelf life: 30
Container: blister Al/PVC/PE/PVDC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 18.05.2022
Validity: 18.05.2027
Pediatric warnings: Yes
PIL: PIL_Pazopanib G.L. Pharma 05_2022.pdf  
SPC: SPC_Pazopanib G.L. Pharma 05_2022.pdf  
Safety feature Yes
Data update: 23.05.2022
eu-flag.png sk-flag.png